Gender affirming medical care of transgender youth

被引:48
|
作者
Salas-Humara, Caroline [1 ]
Sequeira, Gina M. [2 ]
Rossi, Wilma [3 ]
Dhar, Cherie Priya [4 ]
机构
[1] NYU, Dept Pediat, Sch Med, Div Adolescent Med, New York, NY 10016 USA
[2] UPMC Childrens Hosp Pittsburgh, Ctr Adolescent & Young Adult Hlth, Pittsburgh, PA USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Evanston, IL 60208 USA
关键词
SEX HORMONE-THERAPY; BONE-MINERAL DENSITY; TESTOSTERONE REPLACEMENT THERAPY; CENTRAL PRECOCIOUS PUBERTY; CYPROTERONE-ACETATE; AGONIST TREATMENT; ANALOG TREATMENT; BREAST-CANCER; VENOUS THROMBOEMBOLISM; TRANSSEXUAL PATIENTS;
D O I
10.1016/j.cppeds.2019.100683
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The number of gender diverse and transgender youth presenting for treatment are increasing. This is a vulnerable population with unique medical needs; it is essential that all pediatricians attain an adequate level of knowledge and comfort caring for these youth so that their health outcomes may be improved. There are several organizations which provide clinical practice guidelines for the treatment of transgender youth including the WPATH and the Endocrine Society and they recommend that certain eligibility criteria should be met prior to initiation of gender affirming hormones. Medical intervention for transgender youth can be broken down into stages based on pubertal development: pre-pubertal, pubertal and post-pubertal. Pre-pubertally no medical intervention is recommended. Once puberty has commenced, youth are eligible for puberty blockers; and post-pubertally, youth are eligible for feminizing and masculinizing hormone regimens. Treatment with gonadotropin releasing hormone agonists are used to block puberty. Their function is many-fold: to pause puberty so that the youth may explore their gender identity, to delay the development of (irreversible) secondary sex characteristics, and to obviate the need for future gender affirmation surgeries. Masculinizing hormone regimens consists of testosterone and feminizing hormone regimens consist of both estradiol as well as spironolactone. In short term studies gender affirming hormone treatment with both estradiol and testosterone has been found to be safe and improve mental health and quality of life outcomes; additional long term studies are needed to further elucidate the implications of gender affirming hormones on physical and mental health in transgender patients. There are a variety of surgeries that transgender individuals may desire in order to affirm their gender identity; it is important for providers to understand that desire for medical interventions is variable among persons and that a discussion about individual desires for surgical options is recommended.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Facilitators of Gender-Affirming Medical Care for Transgender and Nonbinary Adolescents
    Kahn, Nicole F.
    Spence, Chapin
    Bocek, Kevin
    Sethness, Janis L.
    Kidd, Kacie M.
    Asante, Peter G.
    Coker, Tumaini R.
    Richardson, Laura P.
    Christakis, Dimitri A.
    Sequeira, Gina M.
    TRANSGENDER HEALTH, 2025,
  • [22] INFORMED CONSENT MODEL OF GENDER-AFFIRMING HEALTH CARE FOR TRANSGENDER YOUTH
    Kim, Hyun-Hee
    Szilagyi, Nathalie
    Keuroghlian, Alex S.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S17 - S17
  • [23] Political Issues Surrounding Gender-Affirming Care for Transgender Youth Reply
    Park, Benjamin C.
    Das, Rishub K.
    Drolet, Brian C.
    JAMA PEDIATRICS, 2022, 176 (03) : 323 - 323
  • [24] State Restrictions and Geographic Access to Gender-Affirming Care for Transgender Youth
    Borah, Luca
    Zebib, Laura
    Sanders, Hayley M.
    Lane, Megan
    Stroumsa, Daphna
    Chung, Kevin C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (04): : 375 - 378
  • [25] Medical Options for Care of Gender Diverse and Transgender Youth
    Hodax, Juanita K.
    Wagner, Jill
    Sackett-Taylor, Andrew C.
    Rafferty, Jason
    Forcier, Michelle
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2020, 33 (01) : 3 - 9
  • [26] MENTAL HEALTH OUTCOMES IN TRANSGENDER AND GENDER NONBINARY YOUTH RECEIVING GENDER-AFFIRMING CARE
    Wanta, Jonathon William
    Tordoff, Diana
    Collin, Arin
    Stepney, Cesalie Taylor
    Inwards-Breland, David
    Ahrens, Kym
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S224 - S225
  • [27] SUPPORTING TRANSGENDER AND GENDER-DIVERSE YOUTH IN THE ERA OF GENDER-AFFIRMING CARE BANS
    Johnson, Brandon
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2024, 63 (10): : S32 - S32
  • [28] THE IMPACT OF TELEMEDICINE ON ACCESS TO GENDER-AFFIRMING CARE FOR RURAL TRANSGENDER AND GENDER DIVERSE YOUTH
    DeGuzman, Pamela B.
    Lyons, Genevieve R.
    Kimble, April W.
    Sullivan, Mary A.
    Payne, Heather E.
    Azar, Francesca
    Scudder, Margaret A.
    Gray, Susan H.
    JOURNAL OF ADOLESCENT HEALTH, 2023, 72 (03) : S38 - S39
  • [29] Lessons from Grassroots Efforts to Increase Gender-Affirming Medical Care for Transgender and Gender Diverse Youth in the Community Health Care Setting
    Denaro, Aytch
    Pflugeisen, Chaya Mangel
    Colglazier, Tammy
    DeWine, David
    Thompson, Barbara
    TRANSGENDER HEALTH, 2023, 8 (03) : 207 - 212
  • [30] Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study
    Chen, Diane
    Abrams, Mere
    Clark, Leslie
    Ehrensaft, Diane
    Tishelman, Amy C.
    Chan, Yee-Ming
    Garofalo, Robert
    Olson-Kennedy, Johanna
    Rosenthal, Stephen M.
    Hidalgo, Marco A.
    JOURNAL OF ADOLESCENT HEALTH, 2021, 68 (06) : 1104 - 1111